Gait in children with cerebral palsy - Observer reliability of Physician Rating Scale and Edinburgh Visual Gait Analysis Interval Testing Scale

被引:50
作者
Maathuis, KGB
van der Schans, CP
van Iperen, A
Rietman, HS
Geertzen, JHB
机构
[1] Univ Groningen Hosp, Dept Rehabil, Ctr Rehabil, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen, No Ctr Hlth Care Res, Groningen, Netherlands
[3] Univ Profess Educ, Hanzehogesch, Groningen, Netherlands
关键词
cerebral palsy; video gait assessment; gait analysis; visual gait assessment;
D O I
10.1097/01.bpo.0000151061.92850.74
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
The aim of this study was to test the inter- and intra-observer reliability of the Physician Rating Scale (PRS) and the Edinburgh Visual Gait Analysis Interval Testing (GAIT) scale for use in children with cerebral palsy (CP). Both assessment scales are quantitative observational scales, evaluating gait. The study involved 24 patients ages 3 to 10 years (mean age 6.7 years) with an abnormal gait caused by CP. They were all able to walk independently with or without walking aids. Of the children 15 had spastic diplegia and 9 had spastic hemiplegia. With a minimum time interval of 6 weeks, video recordings of the gait of these 24 patients were scored twice by three independent observers using the PRS and the GAIT scale. The study showed that both the GAIT scale and the PRS had excellent intraobserver reliability but poor interobserver reliability for children with CP, In the total scores of the GAIT scale and the PRS, the three observers showed systematic differences. Consequently, the authors recommend that longitudinal assessments of a patient should be done by one observer only.
引用
收藏
页码:268 / 272
页数:5
相关论文
共 25 条
[1]  
[Anonymous], 1996, GAIT POSTURE
[2]   Medium-term response characterisation and risk factor analysis of botulinum toxin type A in the management of spasticity in children with cerebral palsy [J].
Boyd, RN ;
Graham, JEA ;
Nattrass, GR ;
Graham, HK .
EUROPEAN JOURNAL OF NEUROLOGY, 1999, 6 :S37-S45
[3]   Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy [J].
Boyd, RN ;
Graham, HK .
EUROPEAN JOURNAL OF NEUROLOGY, 1999, 6 :S23-S35
[4]   BOTULINUM TOXIN-A IN MANAGEMENT OF CEREBRAL-PALSY [J].
CALDERONGONZALEZ, R ;
CALDERONSEPULVEDA, R ;
RINCONREYES, M ;
GARCIARAMIREZ, J ;
MINOARANGO, E .
PEDIATRIC NEUROLOGY, 1994, 10 (04) :284-288
[5]  
Chutorian A, 1994, INT PEDIAT S1, V9, P35
[6]   Gait analysis alters decision-making in cerebral palsy [J].
Cook, RE ;
Schneider, I ;
Hazlewood, ME ;
Hillman, SJ ;
Robb, JE .
JOURNAL OF PEDIATRIC ORTHOPAEDICS, 2003, 23 (03) :292-295
[7]   Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: A randomised prospective trial [J].
Corry, IS ;
Cosgrove, AP ;
Duffy, CM ;
McNeill, S ;
Taylor, TC ;
Graham, HK .
JOURNAL OF PEDIATRIC ORTHOPAEDICS, 1998, 18 (03) :304-311
[8]   BOTULINUM TOXIN IN THE TREATMENT OF CEREBRAL-PALSY [J].
DENISLIC, M ;
MEH, D .
NEUROPEDIATRICS, 1995, 26 (05) :249-252
[9]  
Drouin LM, 1996, DEV MED CHILD NEUROL, V38, P1007
[10]   INTERRATER RELIABILITY OF VIDEOTAPED OBSERVATIONAL GAIT-ANALYSIS ASSESSMENTS [J].
EASTLACK, ME ;
ARVIDSON, J ;
SNYDERMACKLER, L ;
DANOFF, JV ;
MCGARVEY, CL .
PHYSICAL THERAPY, 1991, 71 (06) :465-472